MBA Students 2026

I discovered a deep interest in technology halfway through my English degree at Dickinson College, and returned to Ghana to put my self-taught web development, software design and product management skills to use.
As Uber’s first country manager in Ghana, I leveraged these skills and Uber’s platform to improve access to transport options, growing trip volumes in the capital city Accra by 11x over 1.5 years and launching a new city, Kumasi.
During a conversation with Ghana’s largest hospital chain (Nyaho Medical Centre) around leveraging Uber to develop an Ambulance-On-Demand product, I was intrigued by opportunities at the intersection of healthcare and technology.
A few years later, I joined Nyaho as Technology Director and led several key projects over the next 3.5 years, including:
– Supervising the development and continuous improvement process for software that powered Nyaho’s COVID-19 testing laboratory (Ghana’s first), leading to over $5m incremental revenue.
– Leading the development, workflow design, and launch of a new ICD-10 compliant Hospital Management System, eliminating over $100k in customization fees for the incumbent HMS.
– Establishing Nyaho’s first Business Intelligence department and tools, saving $80k in labor costs from previously manual data analysis tasks.
– Designing a project to digitize Nyaho’s immaculately maintained 50-year old patient medical record set, transforming them from a $12k yearly storage cost to a $150k yearly revenue generating dataset for use by pharma and diagnostics AI platforms.

I grew up in Ambler, Pennsylvania and graduated from the University of Pennsylvania in 2020 with a B.A. in Biology, concentrating in Neurobiology. At Penn, I spent 3 years working in an ophthalmology lab at the Scheie Eye Institute, where my research focused on the interplay between retinal inflammation and iron accumulation in Age-Related Macular Degeneration.
I joined medical school at Penn in 2021, where I continued to broaden my research experience across multiple disciplines while also discovering my desire to pursue a career in orthopaedic surgery. Early in medical school, I conducted otolaryngology research comparing clinical outcomes in COVID-19 patients who underwent tracheostomy versus intubation. Later, I worked in the Children’s Hospital of Philadelphia to study the bone marrow immune microenvironment in B-Cell Acute Lymphoblastic Leukemia. Now, I am involved in orthopedic surgery research, collaborating on several studies in sports medicine and foot & ankle surgery.
At Penn Med, I also served as Treasurer of the University City Hospitality Coalition, a service clinic for uninsured patients in West Philadelphia, where I realized my desire to pursue a career that involves health care management. I also co-founded the Perelman Barbecue & Joy Society (PB&J) to promote community and wellness among my peers.
I am now taking a year out to complete my MBA at Wharton, where I am excited to learn the management, leadership, and communication skills to leverage my research background and ultimately become a more effective surgeon, consultant, executive, and overall team member.

After graduating from Tufts University in 2020, I joined Humana to help build out the Author by Humana pilot program serving 13,500+ Medicare Advantage members. I was drawn to the whole-person focus of the Author service model and wanted to dig deeper into the behavioral health space, which led me to Eleanor Health. When joining Eleanor, I pivoted from a Brand Marketing role to Product Management – utilizing my experience in brand and CX strategy to enhance the Member App used by thousands of members in their recovery journeys. I also gained deep exposure to the provider experience via product management of the proprietary “Ops Hub” provider tool.

I was born and raised in Locust Valley, New York and studied chemistry at Princeton University. After college I spent a year at the Feinstein Institute for Medical Research as a research assistant, working as part of a team with the aims of investigating the cause of endometriosis and developing a non-invasive test for early diagnosis. I afterwards ventured out from the Northeast to sunny Los Angeles and obtained my medical degree at the Keck School of Medicine of USC. From there, I completed my internal medicine residency training at Baylor College of Medicine in Houston. I finished my trip around the country by moving back to New York City for the final stage of my medical training at Hospital for Special Surgery; I am currently a fellow in the field of rheumatology, specializing in the treatment of musculoskeletal conditions and systemic autoimmune diseases. I have a clinical interest in the use of point-of-care musculoskeletal ultrasound, for which I am pursuing professional certification. My research is focused on exploring the factors that drive hospitalization costs in patients with lupus.

I grew up in the rural town of Cornish, New Hampshire, with my parents and four sisters. I majored in Economics and International Relations at Connecticut College with the intent of becoming an intelligence officer or joining the foreign service. However, I ultimately decided to balance my interest in business and joined Booz Allen’s National Security Consulting team after graduation, where I served as a consultant for government clients across the intelligence, defense, and treasury communities, supporting classified and non-classified cases.
I joined PwC’s Pharmaceutical and Life Sciences Operations Strategy team during the pandemic in 2020. I cemented my passion for biopharma in my first engagement where I led the design and operationalization of leading COVID-19 IV and SOD therapies under Operation Warp Speed. Since then, I have supported a wide range of private and publicly-held organizations across biopharma and medtech, leading strategy, value capture, and enterprise transformation engagements spanning the entire operations value chain.

I grew up in the Bay Area and then attended Vanderbilt where I was a member of the men’s tennis team. After graduating, I began my career as an investment banker at Wells Fargo in their tech, media, and telecom (TMT) group in New York for two years. I then transitioned to later-stage VC, working for three years at Adams Street Partners in the Chicago office, helping lead the healthcare investing practice. We’re investing in series B – E rounds of financing for tech-enabled services and software companies in healthcare (digital health) that are venture-backed. While at Adams Street, I’ve been fortunate to invest in Turquoise Health, DispatchHealth, BillionToOne, and WelbeHealth.

After finishing my MEng thesis in Professor Andrew Lo’s lab at MIT, I started at McKinsey in SF working mostly on marketing and sales projects in technology, telco, and healthcare as well as private equity due diligences. After two years, I joined GI Partners in their healthcare group, where I covered healthcare IT. I spent the last year at Gryphon Investors focused on IT Services. Besides work, I’ve been a mentor for the SEO Scholars program for high schoolers and an alumni admissions interviewer for MIT.

A child of immigrants from South India, I was born in Tennessee and grew up in Arlington, Massachusetts. I attended Dartmouth College and studied economics, environmental studies, and government. Across these disciplines, I sought to understand the decision-making of individuals and communities as they pursue change in a variety of systems – but started to find myself drawn over and over again to healthcare and education.
After graduating, I joined Bain & Company in Boston to learn how to implement change using data, working on teams, and partnering with organizations. Across four years, I worked in a variety of sectors, but developed a healthcare/health equity focus (though with extended stints selling windows and cardboard boxes).
During a six-month “externship” away from Bain, I led growth strategy for SIRUM, a Bay Area-based nonprofit specializing in the donation of surplus medication. My work focused on expanding SIRUM’s reach in cancer care, K-12 education, and women’s health.

I was born and raised in London and moved to the US when I was 18 for university. While at university, I co-founded a start up in the ocean conservation technology space, which fostered an interest in entrepreneurship and early stage companies. I moved to Philadelphia after graduating, I spent 3 years in venture capital, working on deals in the employer sponsored healthcare space. Since then, I’ve worked in private equity at 1315 Capital, working on deals across medtech, healthcare services, pharma and medtech outsourcing, and consumer health.

After graduating from Princeton, I moved to Mumbai, India to pursue a Fulbright research project focused on digital health, orphaned girls, and mental health. During this project, I developed a wellness app that incorporated various social determinants of health I had researched and observed. This experience laid the groundwork for my entrepreneurial endeavor in building Dendrite. Driven by a passion for creating digital therapeutics to increase access to care for underserved groups, I joined the startup Click Therapeutics. Alongside this, I began writing for the Digital Medicine Society and became a venture fellow at Arkitekt Ventures. Most recently, I have been working as a digital health fellow in the division of population health at the NIH, where I continue to advance my mission of leveraging digital solutions to improve health outcomes.

Midwest-born and raised, dual-citizen (parents from Europe). UW-Madison finance/history. Joined M&A team at UnitedHealth Group – focused on tech. Recruited to join Optum Financial, fintech biz of UHG. Lead partnerships and BD for Optum Financial. Launched a JV with Stripe to build a working capital platform for providers, $190M in distributed capital. Started a healthtech newsletter (+7k readers) on the side that I still write. Really interested in how technology can help us all live better lives. Big believer in lifestyle medicine and simplifying healthcare.

I grew up in Bethesda, Maryland and attended the University of Rochester where I majored in Economics and Political Science. After graduation, I worked at Epic Systems and spent three years learning the Electronic Health Records (EHR) industry. While at Epic, I worked on implementing and improving population health and predictive analytics tools for use at Health Systems nationwide. I then transitioned to Deloitte Consulting’s federal health practice in Washington, D.C. where I supported the FDA and developed an understanding of how new regulatory standards are implemented. These experiences helped me gain a more complete picture of the healthcare industry, from regulation to practice.

I attended Wesleyan University for college where I studied Neuroscience and Behavior and Biology and was initially on the premed track. Through certain scientific research experiences, I realized that I was highly interested in benefiting patients’ health through scientific discovery and innovation. I ultimately concluded that research and innovation would enable me to have the widest impact and give me more autonomy and room for exploration than medicine.
After college I joined Brain and Spine Surgeons of New York (BSSNY), a 20-physician multidisciplinary private practice focused on spine and neurosurgical care. At BSSNY I was responsible for building the clinical R&D program. Much of my research focused on conducting practice-wide RWE studies and clinical trials to innovate and standardize care paradigms and drive adoption of value-based care processes. I also worked to develop novel software technologies and integrated these technologies into research and clinical practice to help automate research processes and manage care for at-risk patients.
Through my research I developed a passion for utilizing digital tools to innovate care delivery and improve patient outcomes. This passion inspired me to co-found DTX Medical (DTX), an early-stage healthtech company developing cloud-based software to enhance the patient experience and help providers and payors improve patient-provider communication, provide virtual care, and increase access to care. Using SMS-based proprietary technology to streamline the collection and aggregation/analysis of patient health data, DTX is used by 527 providers across 153 locations with over 10,000 patients.

I grew up in the suburbs of New York before moving to Chicago, where I studied Psychology, Global Health, and Statistics at Northwestern University. Through coursework and personal experiences, I became fascinated by how important yet broken the US healthcare system is, especially for marginalized communities. After graduation, I consulted for health systems on how to leverage technology to support their overall strategy, improve the patient & provider experience, and increase efficiency. I learned about the newest advances in healthcare and became interested in getting closer to patient care. I then joined Oak Street Health, a value-based primary care provider for older adults. On the Growth Partnerships team, I drove initiatives that helped underserved patients access high-quality care. I led Oak Street’s relationship with AARP and managed several enterprise synergy efforts after Oak Street was acquired by CVS. Most recently, I supported Oak Street’s Population Health team to optimize the organization’s Social Determinants of Health strategy.

I was born and raised in a suburb of Philadelphia before attending Boston College, where I studied finance and business analytics. Wanting to hone my skills in machine learning and optimization, I decided to further pursue my interest in data science by earning a master’s degree from Massachusetts Institute of Technology.
Following my time at MIT, I joined Boston Consulting Group’s GAMMA team as a data scientist, where I focused on helping pharmaceutical companies optimize patient targeting via machine learning to ensure that those in need could better access medications.
My experience at BCG solidified my passion for applying data science to the biotech and pharmaceutical space, leading me to Generate Biomedicines, an in-silico drug discovery startup. As a data scientist at Generate, my contributions ranged from analyzing experimental results, to optimizing lab scheduling, and supporting target selection through advance data analytics.
I am convinced that effective usage of data can transform the healthcare space, as it has already begun to. But my experience has made me aware of the current disconnect between that potential and its utilization. My goal is to help bridge that divide, either in industry in a product focused role, or in VC supporting companies dedicated to this mission.

I grew up in New Zealand and moved to the U.S. in middle school. Comparing different healthcare systems was a frequent debate in our household, and I quickly became interested in the institutions, policies, and companies that comprise the U.S. healthcare system. At Princeton, this led me to major in public and international affairs with a minor in global and public health.
After completing my undergraduate degree, I joined the healthcare transactions and strategy team at Berkeley Research Group, where I performed due diligence and provided strategic recommendations on over 25 buy-side engagements with private equity clients across healthcare sectors. This rapid exposure deepened my understanding of the business impacts of health policy and sparked an enduring interest in data analytics and visualization.
After two and a half years, I joined McKinsey & Company to round out my consulting toolkit and understand the operational side. In my first year, I explored diverse industries such as industrial services, food, and consumer packaged goods. However, I was drawn back to healthcare by the people, mission, and compelling data and analytics unique to this field. In the past eighteen months, I have helped several large health systems identify and implement clinical and operational efficiencies, improve their analytical capabilities, and define their service line strategies.

I began my career in biomedical research, studying bacterial genome replication as a model for cancer cell growth and analyzing novel therapeutic approaches for rare immunodeficiency disorders.
I continued exploring emerging healthcare interventions at an accelerator, translating clinician proposals into low-cost pilot studies to assess commercial viability. I also designed a precision psychiatry interface that imposed quantitative structure on the existing behavioral approaches used for Major Depressive Disorder.
Recently, I supported commercialization strategy at a medical device startup.
Looking forward, I am excited to advance innovative solutions in healthcare with an investment-focused lens.

I grew up in the Bay Area, California, and went to Williams College for undergrad where I double majored in Economics and Biology. Then, as a George J. Mitchell Scholar, I lived in Dublin, Ireland, for 1 year and received an MSc in Immunology and Global Health with my masters thesis focusing on comparing US and Irish health care delivery systems using macroscopic economic analysis. I then trained at the NIH as Post-baccalaureate IRTA Fellow for 1 year where I participated in translational immunology research at the National Institute of Alcohol Abuse and Alcoholism.
I started medical school at the Perelman School of Medicine in 2021 with the goal of becoming an oncologist who leads innovative collaborations between medicine, business, and tech to improve the early diagnosis and treatment of cancer. My research as an innovation fellow at the Penn Center for Cancer Care Innovation (PC3I) since has focused on two cornerstones of such innovation: using Artificial Intelligence/Machine Learning-driven algorithms to predict cancer occurrence and flag high risk individuals, and employing economics tools to improve cancer screening rates. I have also interned for Savor Health, a start-up that uses an AI/ML-augmented digital health platform to improve cancer care.

I was born in South Korea and raised in Salt Lake City. I studied Business & Political Economy (BPE) at NYU Stern, then joined Deloitte Consulting, where I spent five years helping large healthcare providers and plans primarily on finance strategy-related issues, including regulatory benchmarking, long-term economic planning, product P&L, and system implementations. On a more personal front, I helped guide my mother through her cancer journey during the pandemic, serving as her care coordinator and translator. This experience exposed me to the complexities and friction in the healthcare system and fueled my desire to make the patient experience smoother and more efficient.

After growing up in Connecticut, I attended Yale University, where I studied Psychology on the Neuroscience track, competed on the varsity cross country and track team, and developed an interest in the business and politics of healthcare through coursework and extracurriculars.
Upon graduation in 2018, I began my career in healthcare consulting at ClearView Healthcare Partners, where I partnered with both large pharmaceutical clients and innovative biotech startups to provide strategic guidance on business needs such as new product planning, global market expansion, and product lifecycle management. Through my work at ClearView, I became interested in getting closer to healthcare delivery and joined Eleanor Health, an innovative care delivery startup treating patients with substance-use disorder via value-based care. I joined Eleanor Health as the second member of the product management team, where I oversaw the implementation of new software, such as our EMR transition to athenahealth, and worked with the engineering team to build novel care management technology for the care providers. After two years of building technology at a care delivery organization, I was interested in learning about the operations of a pure healthcare technology company and joined Zus Health, a healthcare data interoperability startup, where I gained a firsthand perspective on the importance of improving data fluidity for both patients and providers. As Zus’ product marketing manager, my responsibilities ranged from managing our market-facing presence across all platforms and events, testing and iterating on our pitch messaging to prospects and customers, and helping to scale our solution from the digital health startup market to the broader value-based care market.

I grew up along the gulf coast of central Florida in a small city north of Tampa before moving to Durham, North Carolina to attend Duke University. At Duke, I studied computer science and math with the initial intention of becoming a software engineer, but decided to pivot to consulting after a brief stint working at an Internet of Things (IoT) startup. I joined Deloitte Consulting’s New York City office after graduating and for the last 4 years have worked with R&D and medical affairs groups at large biopharma companies to improve clinical trial and medical information operations.

I grew up in Greensboro, North Carolina and attended the University of Virginia, where I studied commerce and political philosophy. After graduating, I joined Oliver Wyman and affiliated to their health & life sciences practice, where I worked with clients to develop their Medicare Advantage plans.
I later joined the Boston Consulting Group, working primarily in consumer and health care. Within consumer, I focused on pricing – ask me about how ketchup and ground beef are priced! Within health care, I supported a national retailer in improving prescription adherence, launching a texting program to ensure patients pick up and take their medication as prescribed. I also advised several private equity firms in health care transactions, ranging from MedTech, pharma, and outsourced manufacturing.

I was born in Seoul and grew up in Hong Kong. After graduation, I spent three years in investment banking at Lazard, focusing on healthcare M&A and activist defense. Following my time at Lazard, I’ve spent the last few years at Apax Partners and THL where I’ve focused on investing in healthcare technology and services, pharma services, and home-based care businesses. Outside my professional roles, I’ve dedicated most of my time volunteering and advising youth education non-profit organizations.

I grew up in Northern New Jersey and went to Northwestern for undergrad. After Northwestern, I worked as a project manager at Epic, a transplant surgery research assistant at Northwestern Memorial Hospital, and a private MCAT tutor. Then I earned my MD from UT Southwestern in Dallas, where I caught the entrepreneurship bug in my final year of school. During an elective rotation in clinical psychiatry, I met my cofounder for Sonara Health. We started the company with the goal of democratizing access to methadone care, flanked by the tailwinds of regulatory change around treatment accessibility spurred by the COVID pandemic. As our Chief Growth Officer, I led our pre-seed and seed fundraises (from VCs, health plans, strategics, and UHNW individuals including Mark Cuban), led our enterprise sales efforts (including signing several of the largest groups of methadone treatment centers in the country), was a co-inventor of our patented technology, and recruited our technology team. In the future, I aim to leverage my experience as both a physician and founder to become an early-stage investor in daring new companies that improve the health of society’s most vulnerable patients.

After growing up outside Washington DC, I attended Colby College and studied Mathematics & Economics with a concentration in financial markets. I was very active while on campus; playing for the varsity lacrosse team, co-running Mayflower Hill Capital (student-run investment fund) and volunteering for the One Love foundation. While working to figure out my post-grad plans I interned on Capitol Hill, a naval “destroyer” warship and in real estate, before ultimately spending my junior summer in the Consumer Group at Goldman Sachs in the Investment Banking Division.
I returned to Goldman post-grad full time in the Healthcare Banking group focusing on equity capital markets. The groups’ function is to advise corporates on making the private-to-public transition via IPO and help already public companies access additional capital in the equity capital markets. I spent 3-years at GS, leaving this summer as an associate, and enjoyed my access to impressive healthcare management teams and investors.

I grew up in Mumbai and pursued Chartered Accountancy, a finance heavy course. To drive impact, I moved to BCG and spent ~1.5 years across multiple strategic projects and industries – Financial Services, Social Impact, B2B Startup, Oil & Gas. Post BCG, I moved to GIC’s Private Equity investment team and spent the last 3 years on investing and managing portfolio companies largely in the Healthcare Provider and Consumer space. I spent a significant amount of time with one of our investee companies – Asia Healthcare Holdings (an infertility clinics and women & childcare hospital chain) and helped them add service lines, include feeder center strategy for care continuum, and expand through organic/ inorganic means.

I grew up an hour outside of New York City and have lived in the city for the last four years. For college, I attended Cornell University where I majored in Policy Analysis and Management. While studying the policy development process for different industries, I found myself particularly drawn to the complexity and ever-evolving nature of the healthcare space.
After graduation, I kicked off my career in Deloitte’s Healthcare Consulting practice, providing strategic guidance to some of the largest payors, providers and pharmaceutical companies. As a consultant, I developed a strong interest in the health insurance industry, largely driven by the significant influence payors wield over healthcare accessibility and navigability. This interest led me to join the Corporate Strategy group of Horizon Blue Cross Blue Shield of New Jersey, a regional payor. I spent my time at Horizon leading a variety of initiatives focused on improving the member experience, developing programs to address social determinants of health and aiding providers in their transition to value-based care. Working with different digital products at Horizon piqued my interest in product management, leading me to serve as a pre-MBA product manager summer associate at Sequoia, an insurtech brokerage.

I grew up in Minnetonka, Minnesota and attended Brigham Young University. After my freshman year of college, I spent two years in Mexico doing humanitarian work. After graduating from BYU, I spent two years as an investment banking analyst at Piper Sandler in their healthcare group. Most recently I was a healthcare investor at DW Healthcare Partners where I evaluated new investment opportunities and assisted our existing portfolio companies with M&A and strategic initiatives.

Most recently I worked for 3 years at GTCR, a private equity firm, in the healthcare group where I focused on pharma services, pharma and HCIT investing. I began my career in investment banking at Jefferies where I was a member of the healthcare team as well.

After growing up around Asia and Africa (despite being from the UK), I came to the US to pursue a degree in electrical engineering. Upon graduating, I spent 3 years at Bain & Company in their Texas office, mostly in its Private Equity Group on a healthcare-focused team where I helped advise PE firms on buyouts of healthcare companies. Towards the end of my tenure at Bain, I spent 6 months on externship working for the Clinton Health Access Initiative (CHAI) as a program manager on its Maximum Impact Incubator team. In this role, I engaged with CHAI program and country teams, philanthropic partners, and senior leadership to source, evaluate, prioritize, recommend, and seek funding for highly cost effective health programs in low and middle income countries.

I grew up in Erie, PA, and I went to Penn for undergrad where I majored in Neuroscience and minored in Healthcare Management. In my undergraduate HCM courses, I was introduced to many physicians who had expanded their impact beyond the clinical environment to contribute to advancing healthcare through investing, entrepreneurship, innovation, administrative roles, and other unique career paths. Talking with and learning from these individuals and their experiences inspired me to seek medical schools with dual degree MBA programs.
After graduating from Penn undergrad in 2021, I continued my academic career here at the Perelman School of Medicine. During my time in medical school, I sought out opportunities to apply my knowledge of human health and healthcare systems to have an expanded impact outside of the clinical environment. I served as an investment analyst on the Fund for Health, a joint investment fund between the Wharton School and Penn Medicine which invests in companies influencing social determinants of health. I used this opportunity to source and vet companies within the healthcare vertical.

I attended Vanderbilt University in Nashville, TN as a Cornelius Vanderbilt Scholar, majoring in Biochemistry with a minor in Scientific Computing. During college, I focused on developing new techniques for computational antibody design. After graduating, I began medical school at the Perelman School of Medicine at the University of Pennsylvania, where my interest in Orthopedics led me to enroll in and later TA for the Medical Device course at Wharton. I interned with Parvizi Surgical Innovation during my first medical school summer, reinforcing my passion for contributing to orthopedic medical devices. This experience motivated me to pursue an MBA through Penn’s MD/MBA joint degree program. Concurrently, I joined Regeneron’s JEDI program as a consultant, working on clinical-trial related healthcare projects to further integrate business, innovation, and medicine.

I grew up outside Philly in Washington Crossing, PA and went to Tufts University, where I studied Biochemistry on a premed track. I soon realized I wanted to make a more immediate impact on the business side of healthcare and picked up a Finance minor. After trying out different paths in a genomics startup, investment bank, and health-tech VC firm during college, I found my place in biopharma strategy consulting with Putnam Associates.
I have spent the last ~3.5 years with Putnam in NYC focused on drug development and commercial strategy. My most rewarding projects have been those where I’ve worked on early-intervention, borderline preventative novel therapies. That’s where I want to focus for the rest of my career: shifting healthcare from reactionary measures towards preventative ones.

I’m from Great Falls, VA, and have always been excited by the intersection of technology and policy. I studied economics in undergrad and initially envisioned a career in impact investing, which I explored through roles in finance, consulting, and public policy. Towards the end of my undergraduate experience, I became increasingly interested in healthcare and decided to pursue medical school to support underserved communities more directly and to find new modalities to enhance healthcare delivery in the US. I began my medical education here at Penn, and each year has reinforced my decision to pivot towards medicine. I’m eager to combine my clinical expertise with opportunities to innovate and influence health systems on a broader scale through the MD/MBA with Wharton.

I grew up in the San Francisco Bay Area and later attended the University of Virginia, where I studied Commerce with Finance and Accounting concentrations.
Following graduation, I began my career in NYC at Rothschild & Co, a global investment bank. I worked as an Analyst and then as an Associate across Industrials and Business Services sectors. I enjoyed working with a variety of companies and operating in the transaction space, but wanted to approach transactions from the perspective of an investor.
I pursued private equity to both develop an investor perspective and learn how to help management teams develop and execute upon strategy to address challenges faced throughout the PE investment lifecycle. I joined PPC (Public Pension Capital), a $1.5bn AUM middle-market private equity firm that focuses on Healthcare Services, Industrial Services and Business Services. During my three years at PPC, I was a member of the Healthcare Services team and focused on a broad array of sub-sectors, including medical device contract manufacturing, clinical trial site management, RCM, and physician practice specialties (Anesthesia, Women’s Health, Cardiology).

For the last six years, I’ve been investing in private and public healthcare companies.
In 2018, my career began at Leonard Green, which is a generalist private equity firm based in Los Angeles. For over two years, I spent the majority of my time working on opportunities across healthcare and pharma services. While I was at Leonard Green, we invested in Press Ganey (hospital surveys / data) and WCG (institutional review boards for clinical trials).
In 2020, I joined Route One Investment Company, which is a long/short hedge fund based in San Francisco. For nearly four years, I’ve worked on public opportunities across industries with a particular focus on healthcare. My largest projects at Route One were Oak Street Health (capitated primary care), United Healthcare (payor / provider / conglomerate), and Thermo Fisher Scientific (picks & shovels for life sciences R&D).

I was born and raised in a small town in northern MN before I went to Princeton to study Chemistry. After deciding a Ph.D wasn’t for me, I pivoted to the business side of science and joined the Deals Strategy team at Strategy&, where I’ve spent the last 5 years helping investors and corporate clients design investment strategies, assess specific opportunities, and develop growth or value creation strategies. In my 5 years with the firm, I have worked on projects across the healthcare ecosystem, with particular emphasis on innovative therapeutics (e.g., cell and gene therapies, RNA), pharmaceutical services (e.g., CROs, CDMOs), and HCIT spaces.
Outside of projects, I’ve served on staff councils focused on improving the staff experience, building community, and supporting design and roll-outs of strategic initiatives within PwC.

I grew up in New Jersey and graduated from Rutgers University in 2018. After undergrad, I spent three years collectively in investment banking at Credit Suisse (M&A) and Jefferies (Healthcare). Following my time at Jefferies, I began a role in private equity at Assured Healthcare Partners. At AHP, I spent my time evaluating healthcare services businesses and collaborating with our existing portfolio companies across various subsectors of healthcare, including specialty pharma, women’s health, mental health, and gastroenterology. After two years at AHP, I transitioned to an operating role and joined a women’s health business, Advantia Health. I’ve spent the last year leading our growth strategy efforts and building our strategic partnerships.

I was born in Philly and grew up nearby in Wilmington, DE. I attended NYU and graduated in December 2019 with a degree in Business, with concentration in Finance and Computing & Data Science. After undergrad, I spent two years at Guggenheim Securities in Investment Banking within the Healthcare Services group. At Guggenheim, I spent most of my time focused on the payor / provider space, learning about value based care and helping both primary care and specialty care companies raise capital and secure equity investments. Following my stint in banking, I joined Advent International as a Private Equity Associate on the US Health Care team. At Advent, I started off focused on payor / provider services, but soon after shifted over to pharma services investments where I helped invest in a pharma CDMO business and subsequently focused on carving it out of its parent company and enabling it to shift from a cost-oriented mindset to a focus on growth.

I grew up in Wilkes-Barre, Pennsylvania before moving to Philly to attend Penn for undergrad, where I majored in Biological Basis of Behavior and minored in French & Francophone studies, Health Care Management, and Chemistry. Throughout my time at Penn, I grew increasingly interested in the intersection of healthcare management, entrepreneurship, and technology. After graduating, I spent time working at BCG in the Healthcare and Retail sectors. There, I gained problem-solving and critical thinking skills and deepened my understanding of healthcare systems.
Following my time at BCG, I returned to Penn to pursue my MD at the Perelman School of Medicine. While at Perelman, I’ve worked on various projects. Much of my time has been dedicated to the PennHealthX SDOH Accelerator Program, where I’ve worked with multiple startups focused on health equity initiatives. I also worked at Geisinger as a Medical Student Business Fellow, where I focused on improving hospital processes within an integrated health system, and at the Penn Center for Health Care Transformation and Innovation as an Accelerator Intern, where I collaborated with an interdisciplinary team to improve multiple aspects of the patient experience at HUP.

I grew up in Boston, MA before attending Cornell University where I majored in Computational Biology and minored in Business for Life Sciences. As part of my time at Cornell, I worked as an undergraduate researcher in the Molecular Medicine Department and graduated with a thesis on the structure-function relationship of proteins linked to chronic pain. Having discovered an interest in the intersection between life sciences research, drug development and business, I started my post-grad life as a strategy consultant at Putnam Associates. At Putnam, I focused on commercial and market access strategy cases for mid-size and large pharmaceutical companies. This included projects such as strategic planning for a leading lung cancer therapy, ex-US vaccine pricing strategy, and health claims data analytics. Aside from client-facing work, I held a 6-month term as Putnam’s Diversity, Equity and Inclusion Fellow, supporting the firm’s DEI strategy and spearheading events for social and professional community-building.

I grew up in Chicago in the Hyde Park/Kenwood neighborhood (near the University of Chicago). Global Affairs has been a lifelong interest of mine, so I excitedly enrolled at Georgetown’s School of Foreign Service when it came time to attend college. There, I studied International Economics with a concentration in International Finance and Commerce and a certificate in International Business Diplomacy. Alongside my studies, I was a member of the varsity sailing team, student investment fund, campus ministry and interned at the U.S. Treasury Department among other activities. My time at Georgetown inspired me to pursue a career that lies at the intersection of the public and private sectors.
After graduating college, I joined the investment bank Lazard Frères & Co. in New York City, where I focused on M&A in the telecom sector. Following Lazard, I joined Trivest Partners, a private equity firm based in Miami. At Trivest, I focused on executing investments across a range of industries, with a particular focus on healthcare services. My healthcare investments included a primary care medical practice, a wound care practice, and a pediatric homecare agency. However, my interest in the healthcare sector in large part stems from my time working at a distressed safety-net hospital. In between Lazard and Trivest, I joined the transition team for what was formerly known as Mercy Hospital (the oldest hospital in Chicago). There, I participated in a variety of turnaround initiatives to help the hospital emerge from financial distress. Through this experience, I witnessed firsthand the challenges America’s safety-net hospitals face. As a result, I am now interested in contributing to initiatives aimed at stabilizing the country’s at-risk safety-net hospitals.

I grew up in rainy Seattle, surrounded by scientists who taught me that innovation can drive change (pun intended!). This belief took me to Harvard, where I majored in Neurobiology, balancing my time between conducting stem cell research and competing on the NCAA Division I rowing team. Seeking a global perspective, I spent a year in Latin America on the Trustman Fellowship, conducting public health research and working with Laboratoria, a Google-backed start-up. This experience solidified my commitment to integrating science and technology to improve patient outcomes. As an Engagement Manager at Oliver Wyman, I’ve helped biopharma and diagnostic companies advance innovative therapies, like CAR-T and AI-enabled diagnostics, from R&D through commercialization. One of my proudest moments was helping an early-stage biotech raise Series B funding to launch their first clinical trials for a novel cell therapy. Outside of work, I’ve helped fund healthtech start-ups via the UCSF Rosenman Institute and have continued to find time outside running, backpacking, and skiing.

I grew up in the Bay Area outside of San Francisco and attended Duke for undergrad where I majored in public policy with the goal of ultimately pursuing a mission-driven career. After graduation, I joined Bain & Company in San Francisco as a management consultant to gain a generalist business education and explore a variety of industries. While at Bain, I worked on a retainer team for a growth equity client who invested heavily in healthcare companies, specifically those focused on value-based care. This experience sparked my interest in the healthcare sector.
I then secured an externship at Ounce of Care, a small startup that provides care coordination and wraparound services for Medicaid members living in affordable housing. I decided to leave Bain to further pursue my interest in value-based care at Oak Street Health. At Oak Street, I worked on the growth team on a variety of initiatives including refining Oak Street’s Medicaid and dual patient strategy, developing new strategic format centers that combined Oak Street Health centers with CVS pharmacies, and piloting in-center events dedicated roles.

I grew up in Westport, CT and attended Yale University, where I studied Global Affairs with a focus on Global Health and Development. After graduation, I moved to New York City and joined Boston Consulting Group. I spent 4 years at BCG and was promoted to Project Leader before leaving for my MBA. At BCG, I served in the Healthcare and Financial Institutions Practice Areas. In Healthcare, I led commercial due diligences for private equity firms and operational improvements for large biopharmaceutical clients. I had the opportunity to continue my interest in Global Health when I was selected for BCG’s Social Impact Immersion Program, in which I helped develop and coordinate the UN’s 2023 Sustainable Development Goal Summit in New York. Outside of work, I am an avid singer. In college, I took a gap year to perform with the Whiffenpoofs, the world’s oldest collegiate a cappella group. During my time in the group, we performed ~200 concerts in 25 countries and 20 states.

Born in Helsinki, Finland, I began my career in the financial development rotational program at Thomson Reuters in New York. In addition to honing my technical skills, this period invited me to think more deeply about which career path aligns with my values. Informed by my sister’s journey living with a life-threatening autoimmune disease, I set my sights on following in my father’s footsteps by entering the pharmaceutical industry.
For the past three years at Purdue Pharma, I have helped to lead the business and corporate development process to move the company beyond opioids. In addition to sourcing deals, facilitating diligence teams and crafting term sheets, I led the creation and application of robust financial models for both the firm’s branded and generic pipelines. I have also managed the firm’s investments in and royalty agreements with various biotech firms and a VC fund.  In my free time, I have applied these learnings into a voluntary role on the review and deal execution teams of the impact investing group Cancer Fund.
Post-Wharton, my goal is to continue to do part in bringing new medicines to patients.

Originally from Houston, Texas, I earned a Bachelor’s degree in Food, Nutrition, and Health from the University of British Columbia, followed by a Master’s in Nutritional Science from California State University, Los Angeles. After becoming a registered dietitian in 2018, I joined the Center for Discovery as part of the founding team, building out the dietary program for the largest adolescent residential facility the company had opened to date. Driven to lead a program in its entirety I become a program director for a 24-7 residential facility for women with chronic eating disorders. I led this facility through the most tumultuous times in recent history – the COVID-19 pandemic, while significantly reducing staff attrition and improving patient satisfaction scores. Leveraging my experience operating a facility, I expanded my nutrition therapy practice to also offer consulting services to mental health organization, supporting them in improving their operations to achieve higher standards of care. These experiences have driven me to pursue a career where I can have a broader impact on the delivery of healthcare services.

I was born and raised in the cold suburbs of Minnesota, and I attended Williams College, where I majored in Statistics and Economics. After graduating from Williams, I spent three years in Manhattan at Morgan Stanley in their Healthcare Investment Banking group, working on M&A and IPO transactions across the entire healthcare ecosystem. Following my time at Morgan Stanley, I moved to Chicago and worked for three years at GTCR, a private equity firm, as part of their healthcare team. After GTCR, I spent one year as Chief of Staff at Corza Medical, a medical technology company, where I helped drive strategic and financial initiatives across all four of Corza’s business units.

I was born and raised in Northern Virginia and graduated from Penn State in 2020 with a degree in Actuarial Science. Following undergraduate studies, I spent four years as a consultant in Deloitte Consulting’s health actuarial practice where I specialized in engagements focused on value based care, M&A due diligence, price transparency, and growth strategies. In this role, I have worked with all sizes of health plans and health systems as well as private equity-backed provider groups.
After leading numerous clients transition from fee-for-service to value based payment models, I became interested in operationalizing incentive strategies across the healthcare continuum to drive efficiency. I have helped organizations develop the necessary capabilities to successfully assume financial risk for the total cost of care of their patients/members as well as quantify the impact of operational improvements.

I was born in India and grew up in New Jersey. I studied finance and accounting at the University of Michigan – Stephen M. Ross School of Business. I began my career as an investment banking analyst at Wells Fargo Securities in the Mergers & Acquisitions group. After three years at Wells Fargo, I joined Insight Equity, a middle-market private equity firm based in New York and Dallas. After ~8 months at Insight Equity, I joined GTCR in New York to help launch its newly raised middle-market investment vehicle. At GTCR, I was primarily focused on healthcare private equity investments across the medtech and healthcare services sectors.

I was born and raised in the Chicagoland area, and, in 2020, I graduated from Harvard University with a major in Chemical and Physical Biology and a secondary in Global Health and Health Policy. In the latter part of high school, and during my time as an undergraduate, I developed a passion for healthcare innovation (in the form of translational research) and became very interested in how I can efficiently translate clinical discoveries and therapies to patients. I directly transitioned to medical school at the University of Pennsylvania, where I continued to conduct research on both systemic healthcare innovation as well as disease-specific disciplines in hemato-oncology. Following three years of medical education and research, I took a research year from medical school and joined an invaluable mentor of mine to both conduct research on Castleman disease and to work to advance Every Cure (a non-profit biotechnology organization with offices here in Philadelphia). I look forward to leveraging my background in medicine, social impact, and healthcare innovation research to the amazing community at Wharton!

I grew up in Briarcliff, NY, then attended Amherst College where I played soccer for three years. Marrying my passion for art, math, and social sciences, I double majored in Architectural Studies and Psychology, completing an honors thesis on the neglect of architectural design in American schools.
After graduating in 2019, I joined PowerAdvocate, an energy-focused software and consulting firm based out of Boston, MA, where as an associate on the strategy development team I learned an incredible amount about tech-firm operations, sales, and the energy sector. I particularly enjoyed the problem-solving elements of my role and was always excited when I could identify an actionable solution for a client.
That interest in client-focused problem-solving ultimately led me to a role in consulting at Putnam Associates, a boutique life sciences strategy consulting firm also based out of Boston. Since joining Putnam in 2021 (and moving to the NYC office in 2023), every day has brought a new challenge – from understanding barriers to gene therapy utilization, to quantifying the potential opportunity for cancer vaccines or predicting the impact of the Inflation Reduction Act on drug uptake. The experience has exposed me to the incredible depth, complexity, and ingenuity of the healthcare industry, but I know it is just the tip of the iceberg, and I am excited to discover more through the HCM program.
More broadly, working for the last five years in two of the most globally impactful industries has bolstered my long-standing desire to understand and help tackle large societal issues, and I am excited at Wharton to dig deeper into ways business solutions can help resolve some of those complex challenges.

I grew up outside St. Louis, MO, and attended Indiana University where I majored in Finance and Accounting. After graduating from IU, I began my career at Moelis & Company in New York City as an investment banking analyst working as a generalist across both industries and products. I’ve always been interested in healthcare so after two years at Moelis, I transitioned to Cressey & Company, a middle-market healthcare private equity firm in Chicago. During my two years at Cressey, I helped evaluate new opportunities, develop and refine investment theses in pharma services and other healthcare segments, and support existing portfolio companies with growth initiatives.

I was born and raised in Columbus, Ohio and went to MIT for undergrad where I studied Biological Engineering. After graduating from MIT, I worked at Evercore in the Healthcare Mergers & Acquisitions Advisory group based out of NYC for the last four years. At Evercore, I advised healthcare clients across various sub-industries but primarily focused on the life sciences sector, which includes pharma and biotech companies. Throughout my time at Evercore, I worked on a wide range of deals including buy-sides and sell-sides and various types of equity offerings. I enjoyed working closely with management teams and advising them on some of the most critical and exciting points in their business life cycles.

I grew up in a small town in Massachusetts and then went to Colgate University where I majored in Mathematics. After graduating in 2020, I then started my career at Deloitte Consulting. Initially, I worked on projects across a few different industries, but never felt my interest pique as much as when I entered the life sciences space. Over the course of the past three years, I have continued to foster this interest and stayed in the LS space working with mid- to large-size biopharmaceuticals. I helped clients refresh their clinical trial strategy, design and develop executive operating models, conduct cost realignment, and create novel approaches to determine the impact of every-day activities. Most of my work has been focused in the R&D space, with a bit in Medical Affairs and Commercial, which I hope to explore more.

I grew up outside of Pittsburgh, PA and attended the University of Pittsburgh where I graduated with a B.S. in Biomedical Engineering. During that time, I performed research at the McGowan Institute for Regenerative medicine, and spent a summer performing research at the NIH on endogenous retrovirus expression in renal cell carcinoma. After graduation, I matriculated to the Perelman School of Medicine at the University of Pennsylvania, where my love for basic science research evolved into a passion for epidemiological and health economics research. I primarily study disparities in access to care amongst underrepresented populations using large institutional and national databases, under the mentorship of Dr. Giorgos Karakousis and Dr. Junko Takeshita. I also interned at the Center for Healthcare Innovation, where I worked on several projects with various departments aimed toward optimizing efficiency in care delivery with the goal of improving access to care. During my clinical year, I discovered a love for Dermatology, and plan to attend residency after matriculating. In addition to research, I am passionate about advocacy for healthcare reform and helped organized the 2024 Pennsylvania Dermatology Trainee Advocacy Day.

I grew up in Bannockburn, Illinois and studied finance and accounting at Indiana University. In 2019, I graduated and started my career as an investment banking analyst at Lazard in the Healthcare M&A group in New York. After two years at Lazard, I joined Lindsay Goldberg, a private equity firm based in New York, where I spent most of my time investing in multi-site behavioral health. After ~8 months at Lindsay Goldberg, I moved to Chicago to join GTCR where I primarily focused on healthcare investing across tech-enabled healthcare services, supply chain and workflow management software and multi-site physician services.

Born and raised in New York, I’ve been passionate about science & healthcare going back to high school, when I originally wanted to be premed. I attended Yale for undergrad where I majored in Molecular, Cellular & Developmental Biology, during which I researched the application of stem cells for clinical use. After graduating, I saw consulting as a way to bridge the gap between my liberal arts background and developing my pre-professional skillset; upon graduating, I joined the Boston Consulting Group. Now a Project Leader at BCG, I’ve intentionally focused on healthcare for almost all of my casework, including big pharma, med tech, and digital health. Functionally, my work has spanned strategy, due diligence, digital transformation, and operations / supply chain.

My career is all about innovation and business in healthcare.
I began my career in science, with a BSc in Biotechnology and Food Engineering and an MSc in Neuroscience, graduating Magna Cum Laude. I have worked as an R&D researcher in various fields, including hyperbaric medicine, neurobiology, oncology, and metabolics. Throughout my career, I have collaborated with top universities, secured significant grants, and published five scientific papers, appearing as the first author in four of them.
Over time, I discovered my true passion – business and innovation in healthcare. Before pursuing an MBA, I was an Innovation and Project Manager at ALYNnovation, the innovation space of ALYN Hospital, where I worked with international accelerators, investors, and patients to drive transformative projects in pediatric and rehabilitation technology. Additionally, I volunteer as a medtech hackathon mentor.
Previously, as a Business Development Manager at Pharmaseed Ltd., a life science and health care CRO, I forged international partnerships to drive forward innovation within the company, and modernized the company’s marketing and sales strategies. Earlier, at New Phase Ltd., a cancer treatment startup, I worked as a Product Manager and Researcher, gaining insights into the translational journey (‘from bench to bedside’) of novel products, and managing clinical trials.

I am from Dallas, Texas, where my upbringing was influenced by a family of medical professionals, including my father, sparking my passion for healthcare at an early age. I attended the University of Texas at Austin, where I studied Mathematics and Psychology, combining my interests in quantitative analysis and human behavior.
From there, I worked at BCG for two years, where I got the opportunity to blend these two interests across a range of sectors. Driven by my interest in healthcare, I then transitioned to Grow Therapy, a Series A mental health startup, where I applied my prior learnings to attract, retain, and improve care for both patients and therapists in the mental health realm.
Beyond my professional endeavors, my passion for proactive healthcare solutions—such as gut health, longevity, and optimal health—has led me to engage in community projects, conduct personal experiments, and extensively research these areas. At Wharton, I am eager to continue learning and contributing meaningfully to the field and to expand my impact even further.

I was born in Philadelphia and raised in Lower Merion, a suburb just outside of the city.  I attended Penn State University and initially pursued a pre-med academic track. Like many, I found a greater passion for the business and operations of health care and decided to transition and obtain a Bachelors and Masters in Health Administration.
Upon graduation, I joined Veralon, a boutique health care management consulting firm based in Philadelphia, where I specialized in physician service arrangements and strategic planning for physician groups and health systems. We helped health systems and hospitals through physician employment contracting, performed financial feasibility analyses for capital projects, and provided independence assessments for community hospitals. After nearly four years in consulting I felt detached from patient care and sought a move to a provider organization so I could be closer to care delivery.
Eventually I transitioned to an in-house strategic operations role at PRISM Vision Group, a large private equity backed Ophthalmology group concentrated in the Mid-Atlantic US. I served as a generalist at PRISM and was eventually promoted to oversee our Special Projects Department responsible for annual planning and corporate strategic initiative implementation. Our projects were variable and far reaching, ranging from a virtual scribe model implementation to supplement in-office staff shortages, partnering with a care management company to provide out-of-office care management services to patients, and overseeing the operations of new drug launches within our practices.

I grew up in Los Angeles, California with a strong passion for science from an early age. I frequently explored academic research with my father, an astronomy professor at UCLA, and I developed a personal interest in plant biology and ecological world around me.
I attended UC Berkeley, where I pursued a dual degree in Business Administration (through the Haas School of Business) and Economics. As an undergraduate, I continued to nurture my interest in science as a research intern focused on earthquake early-warning systems at the Berkeley Seismological Laboratory. I eventually focused on a career in finance, as an intern and subsequent full-time Associate on the Leveraged Credit team at KKR & Co in San Francisco.
At KKR, I covered a wide range of industry sectors and eventually specialized in Healthcare. I was offered the opportunity to lead the team’s Life Sciences investments in the newly-formed KKR convertible bond fund, and realized that I wanted to explore my interest in this area further. I spent a year volunteering in the CPMC Van Ness ICU in my spare time, and I was captivated by the ability of the Healthcare industry to drive positive outcomes for patients and care providers. My volunteer experience made me think critically about my role and my ability to meaningfully contribute to the industry’s future. Thus, I aspire to specialize further as a Life Sciences investor and create tangible impact within both the Healthcare industry and society more broadly.

I am Latina and a first-generation American. I grew up in Miami, FL, and attended the University of Miami. After graduating, I began my professional career at Nicklaus Children’s Hospital within their foundation as a Development Associate of Annual Giving. In my role, I leveraged the hospital’s needs to align with donors’ passions to build that bridge and push Nicklaus Children’s Hospital’s mission forward. I led one of the hospital’s most successful Spread Toy Drive, collecting over 30,000 toys valued at over $600,000 and raising $67,000 in monetary gifts.
I was promoted to Senior Development Associate of Annual Giving, where I engaged in more strategy conversations on Annual Giving’s essential role within the capital campaign the hospital was in. At Nicklaus Children’s Hospital, I was also exposed to the hospital executive leadership team through foundation events and collaborations. I gained insight into their roles and heightened my interest in health care.
I am passionate about giving back to the community, so I was very involved with Leadership Miami, a hands-on program run by the Greater Miami Chamber of Commerce that focuses on community issues and leadership skills through seminars, and a leadership curriculum developed in partnership with local universities. A critical component of the program is a volunteer service project of a team’s choosing with a 100-day completion goal. I was the lead for my team, Ignite. We partnered with CARE Elementary School and raised $42,000 for our project. We built and stocked classroom libraries for students in each grade level at CARE, organized CARE’s first-ever book fair, hosted various author visits, remodeled the teachers’ lounge, and furnished CARE’s new Pre-K 4 classroom, We also secured books for years to come for CARE through community engagement. Leadership Miami recognized Ignite with the Outstanding Project of the Year award.

After my cohort, I continued my involvement and became a facilitator for the Trailblaz3rs in the Spring 2024 cohort. I mentored a team of 12 and guided them through the different program components. We partnered with Camillus House to build a community garden in their transitional housing residence for 140 homeless families based in Greater Miami and establish educational programming for residents on gardening and sustainability. Again, my team, Trailblaz3rs was recognized by Leadership Miami for Outstanding Project of the Year and Cohort.

I attended Tufts University where I studied International Relations and Chinese. I began my career as a consultant at Simon-Kucher where I supported healthcare companies in creating go-to-market and pricing strategies for novel agents and technologies primarily in oncology and rare disease spaces. Afterwards, I joined Sandbox Industries to learn more about payers and to get closer to healthcare innovation. At Sandbox, I supported various Blue Cross Blue Shield plans in an advisory role where I developed diversification and commercialization strategies. I also had the opportunity to support some venture investment opportunities by collaborating with my colleagues who managed the Blue Venture Fund.

I grew up in the suburbs of Boston before studying Biology and Economics at Washington University in St. Louis. Following graduation I worked in life sciences strategy consulting, working with pharma and biotech organizations to understand the market opportunity and strategic considerations for their clinical-stage therapeutic programs. After 3 years in consulting, I moved to corporate development and strategy at smaller biotechs developing advanced modalities for oncology: ElevateBio focused on cell and gene therapy, and Alpha-9 Oncology developing radiopharmaceuticals. Working at Series B-D stage start-ups, my role included portfolio strategy, financings, and licensing / collaborations with pharma and academic partners. I am most interested in the clinical and economic factors that drive the adoption of new drugs, particularly for those with novel scientific technologies.

I grew up in San Jose, CA and moved to the midwest to attend the University of Michigan where I studied Industrial and Operations Engineering. In undergrad I was involved in two research labs: one in tissue engineering, where I quickly discovered I did not want a career working in a wet lab, and one in healthcare decision making that focused on modeling chronic disease progression. I then started my career as an Associate Consultant at Bain & Company in the Chicago office before transferring to the San Francisco office in 2022. For the last 2.5 years, I’ve been in the Private Equity Group (PEG) at Bain primarily focused on diligences across the healthcare sector.

I have been working in consulting at BCG for the last ~3 years. During that time, I worked on a variety of projects in the HC space, from facilitating market access for rare disease drugs, to streamlining labeling package processes for FDA review, to developing go-to-market salesforce strategy for various drugs / portfolios. From these experiences, I found projects that directly improved patient access and affordability to be most impactful, which is why I hope to continue working in HC going forward as well. Prior to consulting, I worked in not-for-profit HC investment banking at J.P. Morgan, financing hospitals during the COVID-19 pandemic.

I graduated from the University of Virginia with a major in Commerce in 2019. Since graduating, I’ve worked at both Deloitte and McKinsey where I specialized in market access and manufacturing operations for rare disease drugs. In my last year before attending Wharton, I was the Engagement Manager for the McKinsey Health Institute’s Brain Health team, where we partnered with non-profits, local municipalities, and investors to increase access to mental health care globally. Beyond my professional career, I’ve volunteered with and served on the Board of DC SAFE – DC’s only 24/7 domestic violence intervention service – for the past 4 years, where I am able to see firsthand the intersection of policy and healthcare and try to improve outcomes for survivors in DC.

I am completing my MBA in HCM at Wharton concurrently with a Master’s in Public Policy at the Harvard Kennedy School. Following my time in school, I hope to pivot into public sector work to design and implement inclusive policies that narrow health inequities in the United States.

I grew up in Naperville, IL (western suburbs of Chicago) and attended Villanova University, where I majored in finance and competed on the varsity baseball team for 1.5 years until multiple injuries forced me to hang up the cleats. After graduating, I worked in Baird’s healthcare investment banking group in Chicago, where I provided valuation and marketing support on middle-market transactions across multiple healthcare verticals. I then moved to Cressey & Company, a middle market private equity firm focused exclusively on healthcare technology and services.

I grew up in Miami Beach, FL and graduated from the University of Michigan Ross School of Business in 2020. After undergrad, I embarked on a rewarding career in investment banking. Initially, I honed my analytical skills as a Healthcare investment banking analyst at Jefferies. Seeking a broader perspective, I transitioned to H.I.G Capital, a middle-market private equity firm, where I held a generalist position with a strong focus on the healthcare industry. Throughout my time at both firms, I developed a deep specialization in healthcare services, particularly within the outpatient space. At Jefferies, my specific interest was in the behavioral health and veterinary medicine sectors. Notably, at H.I.G Capital, I played a key role in supporting the firm’s successful acquisition – St. Croix Hospice.

I’m from London, UK. I hold a BS in Surgical and Interventional Sciences (2014) and an MD (2018) from University College London. I began my career in neurosurgery at the National Hospital for Neurology and Neurosurgery in London, where I worked until 2021. During this time, I developed a keen interest in the intersection of medicine and technology, leading me to pursue an MS in Bioengineering from Imperial College London, which I completed in 2022.
Following my master’s, I transitioned into clinical engineering and served as Chief Medical Officer at a hardware engineering startup. This role deepened my understanding that many healthcare challenges extend beyond clinical and engineering issues and are fundamentally business-related. This realisation drives my application to the HCM program, where I aim to leverage my diverse background in operational roles, venture capital/private equity, and entrepreneurship.

I grew up outside of Boston, MA and attended Washington and Lee University, where I majored in math and Chinese. I began my career at Brentwood Capital Advisors in Nashville, a healthcare investment bank. I moved to Great Point Partners, a healthcare private equity firm, to transition into healthcare investing. Most recently, I worked at PSG, a software growth equity firm in Boston, to gain greater exposure to software business while continuing to pursue and develop theses in healthcare software and technology.

Born in Denmark and raised in the UK, I moved to Indiana for my undergraduate studies at the University of Notre Dame. During my time there, I majored in Finance and German, and completed internships with NBCUniversal and PwC. Unsure of my post-graduation path, I made a last-minute decision to pursue consulting, securing a position with BCG Chicago in my senior year.
At BCG, I took advantage of the opportunity to work on a diverse array of cases and project types, building a resume that spans Industrial Goods, Private Equity, ESG, Digital, Health Care, Social Impact, Consumer Goods, and more. As I delved deeper into my work and connected with colleagues I admired, I found my niche within BCG’s Health Care practice. This role has allowed me to engage extensively with the Health Care sector, working alongside clients across nonprofit, MedTech, BioPharma, Payer & Provider, and digital health spaces.
In the summer of 2023, I took a ‘break’ from traditional consulting to begin a 6-month secondment with a Chicago education nonprofit. I became Chief of Staff to the CEO of the Chicago Public Education Fund, a venture philanthropy organization dedicated to empowering school leaders with the support and resources necessary for their schools’ success.
My experiences with BCG Health Care, combined with my work on social impact cases and my time at the Chicago Public Education Fund, have fueled my interest in innovation at the intersection of health care and social impact.

Following graduation from Fordham University in 2010 I worked briefly in pharmaceutical and software sales. In 2013 I decided I wanted to challenge myself and go on an epic adventure. After careful research I decided I was going to enlist in the United States Air Force for a chance to become a Pararescueman (PJ). After finishing the 2.5 year pararescue training pipeline in 2016 I was sent to my first duty station in Las Vegas, Nevada where I had 3 combat deployments.
In 2019 I decided I wanted to challenge myself further and headed to another selection course to try out for a coveted spot at the Air Force Special Mission Unit. After being selected I underwent another 10 months of training for a role as the lead assault medic and technical rescue specialist for the world’s most elite special operations teams. I went on three more combat deployments at this Special Mission Unit.

I grew up in Mumbai, India, and moved to the US to attend Brown University. At Brown, I double majored in Biology and English and launched the university’s first incubator for healthcare entrepreneurs. After graduation, I worked at Bain & Company in Boston with a focus in healthcare, technology and private equity. I spent six months away from Bain on externship at Noom, a weight loss and wellness start-up. I developed a strategy to expand Noom’s insurance coverage, built the foundation for their corporate development strategy and facilitated their first fitness content partnership. Most recently, I completed a pre-MBA internship at 2070 Health, a healthcare venture studio. As part of their New Ventures team, I brainstormed avenues to build US-India healthcare ventures focused on process outsourcing for psychiatry and dental practices.

I was born in India and moved to the USA when I was 5 years old. I’ve pretty much grown up in Maryland ever since and attended the University of Maryland in College Park, where I majored in Biomedical Engineering. Here, I spent a lot of time developing devices for people with disabilities, researching drug delivery through lipid nanoparticles, and running my non-profit called VaccineCare. After undergrad, I immediately started medical school at the University of Pennsylvania in the Fall of 2021. In medical school, I’ve been working with Orthopedic Surgeons, particularly Dr. Neil Sheth, on different clinical research projects. We recently were able to publish a paper that proposed a method to analyze the social impact and investment return of orthopedic centers in global healthcare settings such as Tanzania.
.

I grew up in Purchase, NY, and attended Bowdoin College for my undergraduate degree, attracted by its liberal arts curriculum and tennis program. While there, I majored in Economics and minored in Education. I also represented the Polar Bears in tennis over four years, playing both singles and doubles. Although I had an early interest in medicine due to my father’s profession as a head and neck surgeon, I was particularly drawn to the intersection of finance, economics, and healthcare.
After graduating in 2019, I started my career at Goldman Sachs in their Secondaries Private Equity group. During my first two years, I gained experience in financial accounting, fund accounting, and financial modeling, working across four different fund strategies: Primaries, Secondaries, Co-Investments, and GP Management Equity Stakes. I then specialized in healthcare by joining the Healthcare Private Equity group within the Merchant Bank at Goldman Sachs.
In January 2022, I transitioned to Bond Vet, an early-stage veterinary startup, as Chief of Staff to the CEO. At Bond Vet, I initially focused on building the recruitment function and later contributed to marketing, operations, and finance. Most recently, I led the company’s technology function, exploring how technology can enhance customer experience and patient outcomes.

.

I grew up in Buffalo, NY & attended Harvard University where I majored in Economics with a minor in Computer Science. After graduating from college, I spent three years at Bain & Company in Boston, focused primarily on corporate strategy across a number of industries & commercial diligence for PE firms on healthcare businesses. I then joined Bain Capital as an Associate, where I spent my first year on the Technology team and then two years on the Healthcare team, focused on sourcing and evaluating investments across the healthcare ecosystem while supporting our portfolio companies.

I grew up in Southwest Florida before studying applied mathematics in health economics at Harvard. Prior to Wharton, I spent 5 years at Bain & Company in their New York office. While in a generalist role, the majority of my time was in healthcare strategy, commercial operations for software firms, and private equity due diligence. In 2021, I took a six-month leave from Bain to join Zus Health, a digital health startup focused on data interoperability. In 2023, I completed a six-month rotation in the Office of the CEO, working with Bain’s Worldwide Managing Partner on strategic communications and external initiatives.

I grew up in Mumbai, India. From an early age I’ve had an exposure to India’s healthcare and Pharma ecosystem through my parents work. Later in life, I actively pursued this interest through my volunteer work with Indian Cancer Society. Over the last 3.5 years I’ve also been a part of Bain’s Healthcare Practice in India and South East Asia, where I’ve worked on projects ranging from rolling out financing products for pediatric vaccines, scaling an Ecom channel for consumer health company and developing a wellness center for underprivileged cancer patients. I’ve also worked in VC and healthcare logistics space prior to this.

I grew up in Knoxville, Tennessee and moved to the Northeast to attend Cornell University, where I majored in Biology and minored in Business. While originally pre-med and fascinated by intricate logic puzzles of the human body, after navigating my own chronic illness in Tennessee, I experienced first-hand the barriers to accessing high-quality care and decided to pivot my career senior year to the business side of healthcare. I started my career as a consultant at Accenture Strategy in the Life Sciences practice, advising Fortune 500 pharma companies on digital transformations and commercial strategies. Continuing to follow my interest in digital innovation in healthcare, in 2021, I joined a Series A healthtech startup called Ribbon Health as the first person on the Partnerships team. At Ribbon, I held a variety of roles in Go-To-Market and Strategic Finance.

I grew up on Long Island and went here at Penn, where I studied in the Life Sciences and Management Dual Degree program, majoring in Biology at the College of Arts and Sciences and concentrating in Management at Wharton. Since graduating in 2020, I have worked at Accenture as a strategy consultant. My work has been primarily with our healthcare clients, and more recently I decided to further specialize in the pharmaceutical commercial space. Across my projects, I have gained experience in drug launch and portfolio planning, competitive simulation and readiness, patient and provider experience, and digital health.

I grew up in Los Angeles, California and headed east to MIT, where I studied molecular biology. At MIT, I discovered interests in the institutional challenges that can prevent access to quality healthcare in the U.S. and globally. To explore these passions, I spent a summer improving the U.S. drug regulatory approval process at Booz Allen, traveled to South Africa to research policy response to the HIV epidemic, and worked at the CDC Foundation as a COVID-19 vaccine strike team coordinator. After graduation, I joined McKinsey, where I served biotech, life sciences, and private equity investor clients for three years. I worked on R&D efforts to accelerate the intricate processes of drug development and regulatory approval and on Commercial projects to improve the delivery of approved treatments to patients. I spent my most recent six months as a Fellow at the McKinsey Global Institute think tank, where I analyzed the role of the private sector in addressing environmental, health-related, and poverty-centric crises.

I grew up in South Carolina (just outside Charlotte, NC) and went to University of South Carolina for a year before transferring to Vanderbilt University, where I majored in economics and philosophy. After college, I moved to Atlanta and spent two years at Bain and Company, where I spent my first year in the Private Equity Group and my second year doing general practice work. After Bain, I moved up to Boston to join Charlesbank Capital Partners, where I spent my first year on the healthcare team and my second year on the business and consumer services team. I worked on two platform transactions on the business and consumer services team: Perspective Financial Group (May 2024) and Front Row Group (September 2024). Going forward, I’m pursuing early stage operating roles in healthcare services.

I graduated from Vanderbilt University, where I studied Medicine, Health, and Society and Human and Organizational Development, with a minor in Corporate Strategy. My academic and career pursuits have been fueled by my unwavering commitment to improving access to high-quality health services for underserved populations. I started my career at the Cancer Treatment Centers of America (CTCA), where I held a number of roles across strategy, operations, and product management. During my tenure, I gained experience in strategic program design, operations analytics, digital health product development, cross-functional team management, and project management for large-scale implementations. After my time at CTCA, I joined Guidehouse as a Senior Consultant, focusing on process improvement, strategy, and risk management within the Veteran Health Administration’s Office of Integrated External Networks.

I was born and raised in China and moved to the U.S. for college, where I attended Vanderbilt University, double majoring in Economics and Human and Organizational Development with a minor in Finance. My career began in New York with roles in Investment Banking at Jefferies and Credit Research at Bank of America. Following this, I spent three years at L.E.K. Consulting in the Healthcare Services group, where I conducted due diligence and crafted growth strategy recommendations for private equity clients, healthcare providers, payers, and health tech organizations. This experience not only sharpened my understanding of the U.S. healthcare landscape but also highlighted the pivotal role that private equity and consulting firms play in driving systemic reform.

I was born and raised in Hong Kong and attended a Canadian international school, but always knew I wanted to go to college in America, specifically on the west coast. The powers of manifestation worked and I ended up matriculating at UCLA, where I was first pre-med, but eventually pivoted away from being a medical practitioner after deciding that I’d be able to make a larger impact on the healthcare system by working at the nexus of healthcare and business instead. I began my career at Putnam, a boutique life sciences consulting firm, where I focused primarily on helping large biotech and pharma clients with GTM strategy and planning. Mid-tenure, I moved from SF to NYC and grew interested in the vibrant health-tech scene in the city, leading me to join Nomad Health, a Series D startup with a self-service marketplace platform that facilitates travel nurse placements in health systems across the country. At Nomad, I served as Chief of Staff and partnered with our C-suite on various growth strategy and cost cutting initiatives, and also got a taste of fundraising, debt refinancing, and IPO / M&A due diligence processes. I developed a renewed appreciation for our healthcare workforce and solidified my interest in health tech / digital health as a mechanism for societal improvement.

I was born and raised in Miami, Florida. I moved to New Haven for college at Yale University where I studied Molecular, Cellular, and Developmental Biology, with a focus on how environmental factors impact human health. I just finished my third year of medical school at the University of Pennsylvania. Much of my work before medical school was in the nonprofit sector: I served on the managing board of a free clinic where I provided medical care, social services, and nutrition education to uninsured patients, and I worked with an environmental nonprofit to build food access programs for Spanish-speaking immigrants. I also worked for National Public Radio’s science desk, writing and reporting original episodes on air for their daily science podcast. In medical school, I developed a new curriculum for medical students to learn about community nutrition and culinary medicine. The course culminates in a partnership with local high school students, where our medical students develop menus for community dinners. I’m passionate about health equity, food as medicine, mental healthcare and preventive care.

I grew up between Chicago, Shanghai, and Boston. I attended Cornell University where I majored in Mathematics and Economics. After graduation, I spent two years working in the technology investment banking group at Guggenheim Securities in NYC. Following Guggenheim, I wanted to work more directly with founders, so I moved to San Francisco and spent three years on the Growth Equity team at Norwest Venture Partners where I invested in growth-stage technology and consumer health companies. I then decided to make the investor to operator jump, and worked at two different startups. I was a product manager at Big Health, a Series-C mental health technology company, and built mobile apps to treat anxiety, insomnia, and depression. Most recently before Wharton, I led Product GTM at Rippling, a Series-F HR Tech startup that builds HR, Benefits, payroll, IT, and finance software. I worked on Rippling’s Benefits business that helped companies provide insurance and benefits to their employees.

I grew up in Acton, a suburb of Boston, and later studied Economics at Dartmouth College. Since graduating, I’ve been based in New York. Beginning my career at Goldman Sachs in the Financial Institutions Group, I focused on advising national insurance companies on M&A and capital strategies. Following my involvement in an insuretech company’s going public via SPAC, I shifted my focus to tech companies revolutionizing traditional sectors. Transitioning to EQT’s US buyout team, I invested in tech firms across various sectors, from fintech to Hollywood. I decided to leave private equity to work with early-stage companies and those driven by a mission to create a positive impact. This shift led me to Tomorrow Health, a Series B healthtech startup focused on transforming the home health space. As Chief of Staff to the CEO and founder, I oversee OKR management, investor/board relations, internal communications, and strategic initiatives. My role has deepened my interest in technology enhancing patient outcomes and advancing value-based care. I aspire to innovate in digital health solutions in my future endeavors.